Surgical Outcomes With Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC

Tetsuya Mitsudomi, John V. Heymach, Martin Reck, Janis M. Taube, Shugeng Gao, Yoshitsugu Horio, Jian You, Gaofeng Li, Dinh Van Luong, Somcharoen Saeteng, Fumihiro Tanaka, Stefan Watzka, László Urbán, Zsuzsanna Szalai, Hiroaki Akamatsu, Jin Hyoung Kang, Francisco J. Orlandi, Guzel Mukhametshina, Andreas Pircher, Carlos Henrique Andrade Teixeira, Mike Aperghis, Gary J. Doherty, R Doake, Tamer M. Fouad, David H. Harpole